In breast cancer, BCL3 has been found to be induced under estrogen depletion [18]; it promotes proliferation of the TNBC cell line MDA-MB-468 [19], regulates TGFβ-signaling during breast cancer metastasis [20], and promotes metastasis in erbb2-positive tumors [21]. This evidence concerns the gene BCL3 and breast carcinoma.